Short Interest in Astrana Health, Inc. (NASDAQ:ASTH) Decreases By 23.0%

Astrana Health, Inc. (NASDAQ:ASTH) was the recipient of a large decrease in short interest in February. As of February 28th, there was short interest totalling 1,440,000 shares, a decrease of 23.0% from the February 13th total of 1,870,000 shares. Based on an average daily trading volume, of 346,500 shares, the short-interest ratio is presently 4.2 days. Currently, 3.9% of the company’s shares are sold short.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on ASTH shares. Macquarie upgraded shares of Astrana Health to a “hold” rating in a research note on Monday, December 16th. Bank of America decreased their price target on shares of Astrana Health from $55.00 to $49.00 and set a “buy” rating for the company in a research note on Tuesday, March 4th. Robert W. Baird cut their price objective on shares of Astrana Health from $86.00 to $50.00 and set an “outperform” rating on the stock in a research report on Monday, March 3rd. Truist Financial decreased their price target on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a research note on Monday, January 13th. Finally, Stifel Nicolaus dropped their target price on Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Astrana Health presently has an average rating of “Moderate Buy” and an average target price of $56.83.

Astrana Health Stock Performance

ASTH stock opened at $29.34 on Monday. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. The firm has a market cap of $1.65 billion, a PE ratio of 22.57, a P/E/G ratio of 1.37 and a beta of 1.30. The business has a 50 day moving average of $33.96 and a 200-day moving average of $43.07. Astrana Health has a 12-month low of $23.12 and a 12-month high of $63.20.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37). The business had revenue of $665.21 million during the quarter, compared to the consensus estimate of $617.24 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. As a group, sell-side analysts expect that Astrana Health will post 1.15 earnings per share for the current year.

Institutional Trading of Astrana Health

Large investors have recently added to or reduced their stakes in the stock. Janus Henderson Group PLC bought a new position in shares of Astrana Health during the 3rd quarter valued at approximately $1,164,000. Royce & Associates LP purchased a new position in Astrana Health in the third quarter valued at approximately $6,661,000. Principal Financial Group Inc. bought a new position in Astrana Health during the third quarter valued at $13,383,000. Loomis Sayles & Co. L P purchased a new stake in Astrana Health in the third quarter worth $30,251,000. Finally, Victory Capital Management Inc. purchased a new stake in Astrana Health in the third quarter worth $2,596,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.